ENTRY       D11017                      Drug
NAME        Elapegademase (USAN/INN);
            Elapegademase (genetical recombination) (JAN);
            Elapegademase-lvlr;
            Revcovi (TN)
PRODUCT     REVCOVI (Chiesi USA)
SEQUENCE    AQTPAFNKPK VELHVHLDGA IKPETILYYG RKRGIALPAD TPEELQNIIG MDKPLSLPEF
            LAKFDYYMPA IAGSREAVKR IAYEFVEMKA KDGVVYVEVR YSPHLLANSK VEPIPWNQAE
            GDLTPDEVVS LVNQGLQEGE RDFGVKVRSI LCCMRHQPSW SSEVVELCKK YREQTVVAID
            LAGDETIEGS SLFPGHVKAY AEAVKSGVHR TVHAGEVGSA NVVKEAVDTL KTERLGHGYH
            TLEDTTLYNR LRQENMHFEV CPWSSYLTGA WKPDTEHPVV RFKNDQVNYS LNTDDPLIFK
            STLDTDYQMT KNEMGFTEEE FKRLNINAAK SSFLPEDEKK ELLDLLYKAY GMPSPA
  TYPE      Peptide
REMARK      Therapeutic category: 3959
            ATC code: L03AX21
            Product: D11017<JP/US>
EFFICACY    Enzyme replacement (adenosine deaminase)
  DISEASE   Adenosine deaminase severe combined immune deficiency [DS:H02309]
  TYPE      Enzyme replacement therapy product
TARGET      ADA* [HSA_VAR:100v1] [HSA:100] [KO:K01488]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L03 IMMUNOSTIMULANTS
               L03A IMMUNOSTIMULANTS
                L03AX Other immunostimulants
                 L03AX21 Elapegademase
                  D11017  Elapegademase (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Elapegademase
               D11017  Elapegademase (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               395  Enzyme preparations
                3959  Others
                 D11017  Elapegademase (USAN/INN); Elapegademase (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Adenosine deaminase
                ADA* [HSA_VAR:100v1]
                 D11017  Elapegademase (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11017
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11017
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11017
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D11017
DBLINKS     CAS: 1709806-75-6
            PubChem: 348350489
///
